Jaroslaw S.
- Country
- Poland
- Department
- N/A
Research Overview
- Evaluation of Sodium Oxybate for Reducing Alcohol Consumption and Sustaining Abstinence in Patients with Alcohol Dependence at High Drinking Risk Levels
- Study of Trospium Chloride and Xanomeline Tartrate (KarXT) for Treating Mania in Adults with Bipolar I Disorder
- Long-term Safety Evaluation of Trospium Chloride and Xanomeline Tartrate in Treating Mania or Mixed Features in Bipolar-I Disorder: A Phase 3 Open-label Extension Study
Data & Insights
Has run more than one trial at 42 of 92 partner sites.
Specializations
Addiction Medicine
The investigator specializes in treating alcohol dependency, with particular focus on innovative therapeutic approaches for patients with high-risk drinking patterns.
- Alcohol Use Disorder Treatment
- Risk Level Assessment
- Consumption Reduction Strategies
The research focus encompasses therapeutic interventions aimed at reducing alcohol consumption patterns and supporting long-term abstinence maintenance.
Behavioral Health
Expertise in managing substance use disorders with emphasis on developing treatment protocols for patients with varying levels of alcohol dependence severity.
- Drinking Pattern Analysis
- Treatment Response Assessment
- Recovery Management
The investigator's work involves evaluating therapeutic efficacy in addressing heavy drinking days and promoting sustainable recovery outcomes.
Clinical Therapeutics
Focused on investigating pharmacological interventions for alcohol dependence, particularly examining novel therapeutic compounds for treatment-resistant cases.
- Medication Safety Evaluation
- Treatment Efficacy Assessment
- Clinical Outcome Measurement
Areas of interest include the development and evaluation of therapeutic strategies for managing severe alcohol use disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.